No.

論文名

REG1A expression status suggests chemosensitivity among advanced
thoracic esophageal squamous cell carcinoma patients treated withesophagectomy followed by adjuvant chemotherapy.
1Yusuke Sato et.al.
Ann Surg Oncol.2013 Sep;20(9):3044-51.
C-reactive protein inhibits lymphangiogenesis and resultant lymph nodemetastasis of squamous cell carcinoma in mice.
Tomohiko Sasaki et.al.
2Surgery.2013 Nov;154(5):1087-92.

C-reactive protein reduces the relative number of tumor-associated M2
macrophages and intratumoral angiogenesis in mice.
Kuniaki Kuribayashi et.al.
3Tohoku J Exp Med. 2014 Aug;233(4):249-55.

REG Iα activates c-Jun through MAPK pathways to enhance theradiosensitivity of squamous esophageal cancer cells.
Akiyuki Wakita et. al.
4Tumour Biol. 2015 Jul;36(7):5249-54.

CXCL10 Expression Status is Prognostic in Patients with Advanced
Thoracic Esophageal Squamous Cell Carcinoma.
Yusuke Sato et.al.
5Ann Surg Oncol. 2016 Mar;23(3):936-42.

PD-L1 Expression Is a Prognostic Factor in Patients with Thoracic
Esophageal Cancer Treated Without Adjuvant Chemotherapy.
Akiyuki Wakita et. al.
6Anticancer Res. 2017 Mar;37(3):1433-1441.

Sphingosine-1-phosphate/sphingosine kinase 1-dependent lymph nodemetastasis in esophageal squamous cell carcinoma.
Yuta Kawakita et. al.
7Surg Today.2017 Nov;47（11）:1312-1320

TLR3 expression status predicts prognosis in patients with advanced
thoracic esophageal squamous cell carcinoma after esophagectomy.
Yusuke Sato et.al.
8Am J Surg. 2018 Aug;216(2):319-325.

Epithelial-mesenchymal transition-converted tumor cells can induce T-cell
apoptosis through upregulation of programmed death ligand 1 expression
in esophageal squamous cell carcinoma.
9Aung Kyi Thar Min et. al.
Cancer Med. 2018 Jul;7(7):3321-3330.

No.

論文名Expression, Function, and Prognostic Value of MAGE-D4 Protein in
Esophageal Squamous Cell Carcinoma.
Yasuo Ono et.al.
10
Anticancer Res. 2019 Nov; 39 (11): 6015-6023

High TLR4 expression predicts a poor prognosis after esophagectomy foradvanced thoracic esophageal squamous cell carcinoma.
Yusuke Sato et.al.
11
Esophagus. 2020 Oct;17(4):408-416.

Expression and Malignant Potential of B4GALNT4 in Esophageal Squamous
Cell Carcinoma.
Hayato Baba et.al.
12
Ann Surg Oncol. 2020 Sep;27(9):3247-3256.

Chromobox 2 Expression Predicts Prognosis After Curative Resection ofOesophageal Squamous Cell Carcinoma.
Sei Ueda et. al.
13
Cancer Genomics Proteomics. 2020 Jul-Aug;17(4):391-400.

m6 A demethylase ALKBH5 promotes proliferation of esophageal
squamous cell carcinoma associated with poor prognosis.
Yushi Nagaki et al.
14
Genes Cells. 2020 Aug;25(8):547-561.

IGF2BP3 Expression Correlates With Poor Prognosis in Esophageal
Squamous Cell Carcinoma.
Akiyuki Wakita et. al.
15J Surg Res. 2021 Mar;259:137-144.

Peritumoral CD16b positive-neutrophil accumulation strongly correlateswith regional lymph node metastasis in thoracic esophageal squamous cellcancer.
16
Hiromu Fujita et. al.
Surgery. 2022 Jun;171(6):1535-1542.
High TLR6 Expression Status Predicts a More Favorable Prognosis after
Esophagectomy for Locally Advanced Thoracic Esophageal Squamous Cell
Carcinoma.
17
Yusuke Sato et.al.
Curr Oncol. 2023 May 4;30(5):4724-4735.